Finance

Lists
WGS:NASDAQ
GeneDx Holdings Corp
$87.37
+1.75%
(+1.50) 1D
Sep 9, 2:34:22 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WGS...
Open
$84.22
High
$88.84
Low
$84.00
Mkt. cap
2.61B
Avg. vol.
702.66K
Volume
305.29K
52-wk high
$170.87
52-wk low
$32.21
EPS
-$3.63
Beta
1.99
Shares outstanding
29.82M
No. of employees
1K
Open
$84.22
High
$88.84
Low
$84.00
Mkt. cap
2.61B
Avg. vol.
702.66K
Volume
305.29K
52-wk high
$170.87
52-wk low
$32.21
EPS
-$3.63
Beta
1.99
Shares outstanding
29.82M
No. of employees
1K
News stories
From web sources and news partners
About GeneDx Holdings Corp
CEO-
Employees1.3K
Founded2000
HeadquartersStamford, Connecticut, United States
SectorHealth care provider
Websitegenedx.com
Analyst ratings
Based on 7 analysts giving stock ratings to WGS in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for WGS in the last 3 months.
Highest
Current $87.37
$103.00 (+17.89%)
Average
$82.86 (-5.16%)
Lowest
$63.00 (-27.89%)
Analyst
Recommendation
Action
Price target
Projected
Date
William Bonello
Craig-Hallum
Buy
Maintained
$103.00
+17.9%
08/04/2026
Brandon Couillard
Wells Fargo
Buy
Maintained
$75.00
-14.2%
08/04/2026
Mark Massaro
BTIG
Buy
Reiterated
$90.00
+3%
08/04/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
$90.00
+3%
08/04/2026
David Westenberg
Piper Sandler
Buy
Maintained
$63.00
-27.9%
08/04/2026
Daniel Brennan
TD Cowen
Buy
Maintained
$85.00
-2.7%
07/15/2026
Subbu Nambi
Guggenheim
Buy
Maintained
$74.00
-15.3%
06/29/2026
Tycho Peterson
Jefferies
Buy
Maintained
$100.00
+14.5%
05/27/2026
John Wilkin
Craig-Hallum
Buy
Reiterated
$85.00
-2.7%
05/05/2026
Last report
Aug 3, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.01 / -$0.19
+105.33%beat
Revenue / Est. (USD)
114.44M / 111.18M
+2.94%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
116.74M
120.99M
102.25M
114.44M
Cost of goods sold
32.22M
36.72M
34.04M
36.16M
Cost of revenue
32.22M
36.72M
34.04M
36.16M
Research and development expenses
19.83M
24.54M
19.80M
19.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
67.95M
72.56M
74.59M
76.04M
Operating expense
87.78M
97.10M
94.40M
95.69M
Total operating expenses
119.99M
133.82M
128.44M
131.85M
Operating income
-3.25M
-12.83M
-26.18M
-17.41M
Other non operating income
-1.08M
-2.56M
2.33M
382.00K
EBT including unusual items
-7.39M
-18.23M
-62.42M
-18.26M
EBT excluding unusual items
-4.89M
-15.91M
-24.57M
-18.21M
Income tax expense
247.00K
-564.00K
897.00K
-518.00K
Effective tax rate
-3.34%
3.09%
-1.44%
2.84%
Other operating expenses
-
-
-
-
Net income
-7.64M
-17.67M
-63.32M
-17.74M
Net profit margin
-6.54%
-14.60%
-61.92%
-15.50%
Earnings per share
0.49
0.14
-0.28
0.01
Interest and investment income
-
-
-
-
Interest expense
-562.00K
-520.00K
-717.00K
-1.18M
Net interest expenses
-562.00K
-520.00K
-717.00K
-1.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.22M
-6.85M
-19.38M
-10.69M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps